Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

52 Week High Stocks 
 : 
BSE Healthcare 

 

Here are the top 52 week high stocks from the BSE Healthcare index. To know more about the Index, please visit the BSE Healthcare Live Chart. Also read our detailed report on the pharmaceuticals sector.

COMPANY PRICE (Rs) CHANGE (%) VOLUME ('000) DAY'S H/L (Rs) 52-WEEK H/L (Rs) GET MORE INFO
S&P BSE SENSEX 79,117.11 2.54% - 79,218.19 /
77,226.69 		85,978.25 /
65,547.80 		 More Info 
NIFTY 50 23,873.50 2.24% - 23,956.10 /
23,359.00 		26,277.35 /
19,670.50 		 More Info 
S&P BSE HEALTHCARE 42,969.55 1.23% - 43,045.24 /
42,332.29 		44,906.33 /
29,528.91 		 More Info 
FORTIS HEALTHCARE 687.80 1.07% 66.20 699.00 /
676.15 		690.70 /
356.15 		 More Info 
KIMS 592.00 1.24% 61.74 606.00 /
581.40 		603.95 /
350.02 		 More Info 
PANACEA BIOTECH 406.75 -1.93% 28.94 420.00 /
397.25 		415.35 /
112.70 		 More Info 

Date: November 22, 2024  3:29:59 PM     Only Buyers Only Buyers    Only Sellers Only Sellers   * Mutual Funds that hold this stock


FAQs

What is BSE Healthcare Index?

The BSE healthcare index comprises constituents of the BSE 500 index that are classified under the healthcare sector.

The index is calculated using a float-adjusted market cap weighted methodology.

To filter the best quality stocks from the BSE healthcare index, check out Equitymaster’s Indian stock screener. This screener also allows you to screen stocks based on your own criteria.

Also take a look at our detailed analysis of the best pharma and healthcare stocks in India.

Which are the top BSE healthcare companies?

Based on marketcap, these are the top 5 companies in the BSE healthcare index:

You can see the full list of the BSE healthcare stocks here.

And for a fundamental analysis of the above companies, check out Equitymaster’s Indian stock screener which has a separate screen for top healthcare companies in India.

What is the price of BSE healthcare index live today?

The S&P BSE HEALTHCARE last traded at 42,969.6. It was up 1.2% over its previous close.

Within the BSE Healthcare, the top gainers were KOPRAN. (up 10.0%) and INDOCO REMEDIES (up 8.1%). On the other hand, SHILPA MEDICARE (down 3.1%) and RPG LIFE SCIENCES (down 2.6%) were among the top losers.

For more, please visit the BSE healthcare index live chart and also check out our pharma sector report.

Can we buy the BSE healthcare index?

The BSE healthcare index is a collection of stocks and not a security that is traded on any stock exchange. Hence, we cannot buy it directly.

However, there are ways in which one can invest in the BSE healthcare index.

One can invest in index funds or ETFs representing the index or buying future and options for it.

Which are the other important indices one should track?

Well, it depends on what your goals are.

Having said that, the two key indices to track are the BSE Sensex and the NSE Nifty.

However, these two indices are considered to be too narrow by some, since they only track 30 and 50 stocks, respectively.

For broader tracking, you could use the BSE 200, BSE 500 or even the NSE 500 index.

Some popular market cap based indices include BSE Smallcap index and BSE Midcap index, among others.


Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.